期刊文献+

甲状腺乳头状癌中Survivin,VEGF,EGFR的表达及临床意义分析 被引量:8

Expressions and Clinical Significances of Survivin, VEGF and EGFR in the Papillary Thyroid Carcinoma
原文传递
导出
摘要 目的:探讨甲状腺乳头状癌(PTC)中存活素(Survivin)、血管内皮生长因子(VEGF)、表皮生长因子受体(EGFR)的表达及临床意义。方法:选择2013年4月~2016年4月在我院收治的100例PTC患者的手术标本以及同期100例癌旁正常甲状腺组织为研究对象,采用免疫组化方法检测盒比较Survivin、VEGF、EGFR的表达在PTC及癌旁正常甲状腺组织中的表达及二者的相关性,并分析其Survivin、VEGF、EGFR的表达与PTC患者临床病理特征的相关性。结果:PTC组织中Survivin、VEGF、EGFR阳性表达率均显著高于癌旁正常甲状腺组织,差异具有统计学意义(P<0.05);Survivin、VEGF在淋巴结转移患者中的阳性表达率显著高于无淋巴结转移者(P<0.05);EGFR在女性PTC患者中的阳性表达率显著高于男性(P<0.05)。PTC组织中VEGF和Survivin、EGFR的表达无显著相关性(P>0.05),但Survivin和EGFR的表达显著相关(r=0.235,P<0.05)。结论:Survivin、VEGF、EGFR在PTC组织中表达上调,Survivin、VEGF与PTC的淋巴结转移有关,Survivin和EGFR在PTC的发生、发展过程中可能存在着协同作用。 Objective: To study the expressions and clinical significances of survivin, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor(EGFR) in papillary carcinoma of thyroid (PTC). Methods: 100 patients with PTC who were treated in our hospital from April 2013 to April 2016 were selected as the research objects and another 100 cases with normal thyroid tissues adjacent to cancer were selected as the control group. Then the expressions of EGFR, VEGF and survivin and their correlation with the pathological characteristics were analyzed. Results: The positive expressions of survivin, VEGF and EGFR in PTC tissues were higher than those of the normal thyroid tissues (P〈0.05). The positive rates of VEGF and survivin in lymph node metastasis were higher than those of patients without lymph node metastasis (P〈0.05). The positive expression of EGFR in female patients was higher than that of male's (P〈0.05). There was no significant correlation between VEGF, Survivin and EGFR (P〉0.05), and there was correlation between survivin and EGFR (P 〈 0.05). Conclusion: In the occurrence and development of PTC, the expressions of survivin might be related to lymph node metastasis, and there might be a synergistic effect between survivin and EGFR, providing preliminary experimental evidence for targeted drug action in the treatment of PTC.
出处 《现代生物医学进展》 CAS 2017年第16期3111-3113,3121,共4页 Progress in Modern Biomedicine
基金 云南省自然科学基金项目(2004FZ123)
关键词 甲状腺乳头状癌 存活素 血管内皮生长因子 表皮生长因子受体 Papillary thyroid carcinoma Survivin Vascular endothelial growth factor Epidermal growth factor receptor
  • 相关文献

参考文献4

二级参考文献89

  • 1卢秀波,安兆峰,王庆兆,殷德涛,邱新光.Survivin和c-myc在分化型甲状腺癌中的表达及临床意义[J].中华实验外科杂志,2004,21(6):705-706. 被引量:18
  • 2董文荣,李晓明,路秀英,邸斌,马婧,崔丽萍.Survivin在分化型甲状腺癌组织中的表达及其与肿瘤微血管形成的关系[J].临床耳鼻咽喉科杂志,2006,20(21):967-969. 被引量:2
  • 3王化修,伍石华,蒙松年,肖小芹,杨华,张灿云.存活素和CD44 V6在甲状腺癌组织中的表达及意义[J].实用癌症杂志,2006,21(6):588-590. 被引量:8
  • 4Su JL, Chen PS, Chien MH, et al. Further evidence for expression and function of the VEGF - C / VEGFR - 3 axis in cancer cells [J]. Cancer Cell, 2008,13(6):557-560.
  • 5Raica M, Cimpean AM, Ceausu R, et al. Lymphatic microvessel density, VEGF - C and VEGFR - 3 expression in different molecular types of breast cancer [J]. Anticancer Res,2011,31(5):1757- 1764.
  • 6Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phos- phatase gene mu -rated in human brain, breast,and prostate cancer [J]. Science, 1997,275:1943.
  • 7Siironen P, Ristimaki A, Narko K, et al. VEGF - C and COX - 2 expression in papillary thyroid cancer [ J ]. Endocr Relat Cancer, 2006,13 ( 2 ) :465 - 473.
  • 8Lee SH, Kiln HS, Park WS, et al. Non small cell lung cancers fre -quency express phosphorylated Akt:an immunohistohemical study [J]. APMIS,2002,110(7/8) :587 -588.
  • 9Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGIR - 3 suppresses angiogenic sprouting and vascular net-work formation [ J ]. Nature ,2008,454 ( 31 ) :656 - 660.
  • 10Harrel] MI, lritani BM, Ruddel] A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph t]ow precede melano- ma metastasis [ J ]. Am J Patho1,2007,170 ( 2 ) :774 - 786.

共引文献15

同被引文献55

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部